These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Angiotensin-converting enzyme inhibition during thrombolytic therapy in acute myocardial infarction: the Captopril and Thrombolysis Study (CATS). Kingma JH; van Gilst WH Herz; 1993 Dec; 18 Suppl 1():416-23. PubMed ID: 8125421 [TBL] [Abstract][Full Text] [Related]
8. [Intravenous systemic thrombolysis using streptokinase in the treatment of developing cardiogenic shock in myocardial infarct]. Dvorák K Vnitr Lek; 1990 May; 36(5):426-34. PubMed ID: 2375073 [TBL] [Abstract][Full Text] [Related]
9. A case of prolonged life support. Bercker S; Poloczek S Resuscitation; 2006 Mar; 68(3):434-5. PubMed ID: 16457937 [No Abstract] [Full Text] [Related]
10. Effects of thrombolysis during out-of-hospital cardiopulmonary resuscitation. Stadlbauer KH; Krismer AC; Arntz HR; Mayr VD; Lienhart HG; Böttiger BW; Jahn B; Lindner KH; Wenzel V Am J Cardiol; 2006 Feb; 97(3):305-8. PubMed ID: 16442386 [TBL] [Abstract][Full Text] [Related]
11. Thrombolytics in CPR. Current advantages in cardiopulmonary resuscitation. Spöhr F; Böttiger BW Minerva Anestesiol; 2005 Jun; 71(6):291-6. PubMed ID: 15886590 [TBL] [Abstract][Full Text] [Related]
12. Thrombolysis and other drugs during cardiopulmonary resuscitation. Spöhr F; Wenzel V; Böttiger BW Curr Opin Crit Care; 2008 Jun; 14(3):292-8. PubMed ID: 18467889 [TBL] [Abstract][Full Text] [Related]
13. Thrombolytic therapy vs primary percutaneous intervention after ventricular fibrillation cardiac arrest due to acute ST-segment elevation myocardial infarction and its effect on outcome. Richling N; Herkner H; Holzer M; Riedmueller E; Sterz F; Schreiber W Am J Emerg Med; 2007 Jun; 25(5):545-50. PubMed ID: 17543659 [TBL] [Abstract][Full Text] [Related]
14. Altered electrical activity of fibrillation process following thrombolytic therapy in out-of-hospital cardiac arrest patients with sustained ventricular fibrillation. Lederer W; Schlimp CJ; Niederklapfer T; Amann A Med Hypotheses; 2006; 67(2):333-5. PubMed ID: 16549275 [TBL] [Abstract][Full Text] [Related]
15. Thrombolytic therapy during or after cardiopulmonary resuscitation. Efficacy and safety of a new therapeutic approach. Spöhr F; Böttiger BW Minerva Anestesiol; 2003 May; 69(5):357-64. PubMed ID: 12768167 [TBL] [Abstract][Full Text] [Related]
17. [Rescue thrombolysis with repeated doses of streptokinase in acute myocardial infarct. A preliminary report]. Arriaga Nava R; Olivas Bojórquez M; Jerjes-Sánchez C Arch Inst Cardiol Mex; 1995; 65(4):323-9. PubMed ID: 8561653 [TBL] [Abstract][Full Text] [Related]
18. Thrombolytic therapy use for acute myocardial infarction and outcome in Qatar. Hadi HA; Al Suwaidi J; Bener A; Khinji A; Al Binali HA Int J Cardiol; 2005 Jul; 102(2):249-54. PubMed ID: 15982492 [TBL] [Abstract][Full Text] [Related]
19. In-hospital prognosis of patients with acute myocardial infarction complicated by primary ventricular fibrillation. Volpi A; Maggioni A; Franzosi MG; Pampallona S; Mauri F; Tognoni G N Engl J Med; 1987 Jul; 317(5):257-61. PubMed ID: 3600719 [TBL] [Abstract][Full Text] [Related]
20. Impact of metabolic syndrome on coronary patency after thrombolytic therapy for acute myocardial infarction. Yasar AS; Bilen E; Bilge M; Arslantas U; Karakas F Coron Artery Dis; 2009 Sep; 20(6):387-91. PubMed ID: 19696662 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]